( Hong Kong, China | November 13–14, 2026 )
From November 13 to 14, 2026, Qingdao MacroAlga Biotechnology Co., Ltd. attended the Founding Ceremony of the Biostimulants Asia Alliance (BAA) and the 1st Congress on Biostimulants and Sustainable Agricultural Development in Hong Kong, as one of the alliance’s founding members. Kevin ZHANG, General Manager of MacroAlga, delivered the company presentation on the pure enzymatic seaweed platform.
Held at the Regala Skycity Hotel, the two-day programme opened with a working session on the BAA Charter and its strategic development roadmap, bringing together principal founding enterprises and the heads of national industry associations from China, Japan, Korea, Southeast Asia and other regions. The Founding Ceremony followed on November 14, formally establishing Asia’s first industry alliance dedicated entirely to biostimulants.

The Founding Ceremony of the Biostimulants Asia Alliance and the 1st Congress on Biostimulants and Sustainable Agricultural Development, Hong Kong, 14 November 2026.
Asia both produces and consumes a large share of the world’s seaweed-based agricultural inputs, yet the category has long been described in inconsistent terms — what counts as an extract, how alginate content is stated, which claims are supported by trial data. The BAA is intended to give the region a shared framework for those questions, and to connect manufacturers, formulators and distributors across national borders.
MacroAlga took part in the Charter discussion and put forward a single position: that a transparent production process and data-driven validation should be the baseline for the category, not a marketing option. The company’s own practice — an enzymatic route with nothing added but enzymes, and every formula verified before release — was presented as one working example of that principle.

Discussion of the BAA Charter and Strategic Development Roadmap, 13 November 2026, Hong Kong.
MacroAlga’s story began with a single enzyme. Working with the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT), Chinese Academy of Sciences, the company took alginate lyase from a laboratory result to a stable, industrial-scale enzyme — and built the entire seaweed business around it.
Today, every drop of MacroAlga’s seaweed extract is produced by self-produced enzymes — cellulase, alginate lyase and fucoidanase — acting at 40–50 °C under near-neutral conditions. No acid. No alkali. No chemical reagents. The result is a fully soluble extract rich in defined low-DP oligosaccharides, with heat-sensitive actives preserved, a low salt load suited to foliar and drip application, and clean chelation of trace elements.
Four brown seaweeds run on one platform: fresh kelp received daily at the Gaomi plant, plus Ecklonia maxima, Ascophyllum nodosum and Durvillaea potatorum on the dry-algae route. From pulping and enzymolysis to inactivation, ceramic-membrane filtration and concentration, the whole seven-step process runs in-house — so quality never leaves our sight.

Kevin ZHANG, General Manager of Qingdao MacroAlga, presenting the pure enzymatic seaweed platform.
• Enzymatic seaweed extract (liquid) — the flagship product, straight from the hydrolysis line
• AlgaPep powder — the same enzymatic science in a fully water-soluble powder; potassium-free by process design, with customs classification (HS 31010090) already confirmed for normal export
• Alginate oligosaccharide (AOS) — a new-type fertilizer synergist cut by our own alginate lyase
• Chitosan oligosaccharide (COS) — fully water-soluble, independently verified, known as a plant vaccine
• Protein hydrolysates — chicken-derived peptides
Every formula MacroAlga releases passes three stages of verification: laboratory screening, climate-chamber trials and field demonstrations. Science-rooted, data-driven, crop-proven — the same standard the company argued for at the Charter table.
Questions from the floor centred less on the concept than on the practice: how enzyme activity is held stable at industrial scale, how the extract behaves in high-salinity irrigation water, and whether a potassium-free powder can replace a conventional extract in existing formulations without reformulation. Conversations continued through the round-table dinner, with association representatives from several countries asking about regional registration pathways and local trial support.
The founding of the alliance is a starting point rather than a conclusion. MacroAlga will carry the same platform to the US Biostimulant Conference in Sacramento, December 1–3, 2026, at Booth D20 — where samples, full bioassay reports and the process itself will be open to inspection.
Come and see why the ocean’s generosity deserves a gentler process — Pure Seaweed, Pure Power.
Enzymatic Seaweed Extract — The Platform Behind the Hong Kong Presentation

Group Photo of the Participants at the BAA Founding Conference, Hong Kong.
About Qingdao MacroAlga
Qingdao MacroAlga Biotechnology Co., Ltd. is a leading biotechnology company specializing in the R&D, production, and application of core biostimulant raw materials, including enzymatically hydrolyzed seaweed, chitosan oligosaccharides, alginate oligosaccharides, and protein hydrolysates. Committed to science-based innovation and sustainable agriculture, MacroAlga serves growers and partners worldwide with high-performance, eco-friendly solutions.
Media Contact: info@macroalga.com
Website: www.macroalga.com